Study to Evaluate the Safety, PK, and Efficacy of the Myc Inhibitor OMO-103 Administered iv in Patients With PDAC
Clinical trial NCT06059001 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06059001
- Sponsor
- Peptomyc S.L.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-31
- Primary completion
- 2026-05-31
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.